Zivo Bioscience, Inc. - ZIVO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$1.593M
QoQ value delta ($000)
-$1.855M (-53.8%)
Implied price effect (QoQ)
-46.17%
Shares
Total shares
1,224,074
QoQ shares delta
-202,131 (-14.17%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ZIVO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 1,042 801,870 0.02%
GEODE CAPITAL MANAGEMENT, LLC 360 272,851 0.0%
VANGUARD GROUP INC 170 130,866 0.0%
WELLS FARGO & COMPANY/MN 14 11,328 0.0%
Tower Research Capital LLC (TRC) 6 5,351 0.0%
BARTLETT & CO. WEALTH MANAGEMENT LLC 1 1,000 0.0%
JPMORGAN CHASE & CO 0 9 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 0 629 0.0%
ROYAL BANK OF CANADA 0 170 0.0%